
Sign up to save your podcasts
Or
With a decades-long commitment to psychedelic advocacy and research, a firsthand knowledge of the life-changing benefits of plant medicine, and his role as CEO of Psygen Labs, Danny Motyka brings a unique perspective to the future of psychedelics. In this episode, he and Paul discuss the differences between the cannabis and psychedelic industries, the role of plant medicines as preventative treatments, and what psychedelic therapy might look like in the near future.
4.7
292292 ratings
With a decades-long commitment to psychedelic advocacy and research, a firsthand knowledge of the life-changing benefits of plant medicine, and his role as CEO of Psygen Labs, Danny Motyka brings a unique perspective to the future of psychedelics. In this episode, he and Paul discuss the differences between the cannabis and psychedelic industries, the role of plant medicines as preventative treatments, and what psychedelic therapy might look like in the near future.
10,305 Listeners
1,831 Listeners
2,579 Listeners
615 Listeners
1,241 Listeners
562 Listeners
1,922 Listeners
910 Listeners
957 Listeners
463 Listeners
170 Listeners
230 Listeners
145 Listeners
113 Listeners
7,680 Listeners